Sol Gel Technologies Ltd Revenue Growth Rates (SLGL), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Sol gel Technologies Ltd   (NASDAQ: SLGL)
 

SLGL's Revenue Growth by Quarter and Year

Sol Gel Technologies Ltd 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SLGL Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December 19.39
3rd Quarter September 0.00
2nd Quarter June 17.26
1st Quarter March 0.00
FY 36.65

SLGLs Annual Revenue
Sol Gel Technologies Ltd 's Revenue in the fiscal year 2025 $ 19.39 millions
Sol Gel Technologies Ltd 's Revenue in the fiscal year 2024 $ 11.54 millions
Sol Gel Technologies Ltd 's Revenue in the fiscal year 2023 $ 1.55 millions
Sol Gel Technologies Ltd 's Revenue in the fiscal year 2022 $ 3.88 millions
Sol Gel Technologies Ltd 's Revenue in the fiscal year 2021 $ 31.27 millions




SLGL Revenue fourth quarter 2025 Y/Y Growth Comment
Sol gel Technologies Ltd reported Revenue surge of 68.01% year on year in the fourth quarter 2025, to $ 19.39 millions, this is lower than Sol Gel Technologies Ltd 's recent average Revenue surge of 164.97%.

Looking into fourth quarter 2025 results within Major Pharmaceutical Preparations industry 135 other companies have achieved higher Revenue growth. While Sol Gel Technologies Ltd ' s Revenue jump of 68.01% ranks overall at the positon no. 2820 in the fourth quarter 2025.


SLGL Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December 68.01 % 644.52 % -60.05 % -87.59 %
3rd Quarter September - - - -
2nd Quarter June 217.86 % 820.34 % -83.24 % 278.49 %
1st Quarter March - - - -
FY   115.96 % 692.99 % -71.08 % -

Financial Statements
Sol Gel Technologies Ltd 's fourth quarter 2025 Revenue $ 19.39 millions SLGL's Income Statement
Sol Gel Technologies Ltd 's fourth quarter 2024 Revenue $ 11.54 millions Quarterly SLGL's Income Statement


SLGL Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   115.96 % 692.99 % -71.08 % -


Back to SLGL Growth rate Comparisons >> Back to SLGL Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #136
Healthcare Sector #384
Overall #2820

Revenue Y/Y Growth Statistics
High Average Low
642.47 % 164.97 % -87.58 %
(Dec 31 2024)   (Dec 31 2022)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #136
Healthcare Sector #384
Overall #2820
Revenue Y/Y Growth Statistics
High Average Low
642.47 % 164.97 % -87.58 %
(Dec 31 2024)   (Dec 31 2022)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Sol Gel Technologies Ltd 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SLGL's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SLGL's IV. Quarter Q/Q Revenue Comment


Sol Gel Technologies Ltd 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 19.39 $ 11.54 $ 1.55 $ 3.88 $ 31.27
Y / Y Revenue Growth (TTM) 68.04 % 642.47 % -59.98 % -87.58 % 256.54 %
Year on Year Revenue Growth Overall Ranking # 43 # 3686 # 3160 # 0 # 0
Seqeuential Revenue Change (TTM) 68.04 % 642.47 % -59.98 % -87.58 % 256.54 %
Seq. Revenue Growth (TTM) Overall Ranking # 43 # 3686 # 3160 # 0 # 0


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2025 period, Sol Gel Technologies Ltd 's cumulative twelve months Revenue were $ 19 millions, company would post below average annual Revenue growth of 256.54% year on year, if the fiscal year would end at Dec 31 2025.
A slow-down in the Sol Gel Technologies Ltd 's Revenue growth from the 0% growth in Dec 31 2024.

Among companies within the Healthcare sector 12 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 43, from total ranking in previous quarter at 3686.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 5
Healthcare Sector # 13
Overall # 43

Revenue TTM Y/Y Growth Statistics
High Average Low
642.47 %
 156.13 %
-87.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 13
S&P 500 # 43
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2025 period, Sol Gel Technologies Ltd 's cumulative twelve months Revenue were $ 19 millions, company would post below average annual Revenue growth of -87.58% year on year, if the fiscal year would end at Dec 31 2025.
A slow-down in the Sol Gel Technologies Ltd 's Revenue growth from the 0% growth in Dec 31 2024.

Among companies within the Healthcare sector 12 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 43, from total ranking in previous quarter at 3686.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 5
Healthcare Sector # 13
Overall # 43

Revenue TTM Y/Y Growth Statistics
High Average Low
642.47 %
156.13 %
-87.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 13
S&P 500 # 43




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SLGL's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Dec 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2025
Pavmed Inc 116.67%$ 116.667 millions
Macrogenics Inc 113.03%$ 113.032 millions
C4 Therapeutics Inc 112.79%$ 112.787 millions
Vyne Therapeutics Inc 111.90%$ 111.905 millions
Tonix Pharmaceuticals Holding Corp 108.75%$ 108.753 millions
Phathom Pharmaceuticals Inc 94.12%$ 94.121 millions
Tenon Medical Inc 92.34%$ 92.338 millions
Caribou Biosciences Inc 89.74%$ 89.745 millions
Argenx Se89.08%$ 89.078 millions
Sangamo Therapeutics Inc 88.43%$ 88.425 millions
Agios Pharmaceuticals Inc 86.09%$ 86.086 millions
Oculis Holding Ag85.72%$ 85.722 millions
Alnylam Pharmaceuticals Inc 84.95%$ 84.945 millions
Day One Biopharmaceuticals Inc 83.92%$ 83.915 millions
Neuronetics Inc 82.17%$ 82.169 millions
Arcutis Biotherapeutics Inc 81.48%$ 81.478 millions
Aclarion Inc 80.59%$ 80.590 millions
X4 Pharmaceuticals Inc79.08%$ 79.079 millions
Intellia Therapeutics Inc 78.79%$ 78.787 millions
Envoy Medical Inc 78.57%$ 78.571 millions
Organogenesis Holdings Inc 78.13%$ 78.126 millions
Tg Therapeutics Inc 78.00%$ 78.004 millions
Eton Pharmaceuticals Inc 77.14%$ 77.140 millions
Trisalus Life Sciences Inc 76.95%$ 76.954 millions
Co diagnostics Inc 76.74%$ 76.743 millions
Ss Innovations International Inc76.54%$ 76.537 millions
Cellectis S a 75.76%$ 75.760 millions
Fennec Pharmaceuticals Inc 73.84%$ 73.842 millions
Travere Therapeutics Inc 73.41%$ 73.410 millions
Inspiremd Inc 69.30%$ 69.299 millions


About Sol Gel Technologies Ltd Revenue Growth Rates (SLGL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Sol Gel Technologies Ltd (CIK 1684693).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001178913-26-001552
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Sol Gel Technologies Ltd’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.